Results 181 to 190 of about 79,111 (213)
Some of the next articles are maybe not open access.
Angiotensin II receptor blockers: review of the binding characteristics
The American Journal of Cardiology, 1999Several angiotensin II receptor blockers (ARBs), including candesartan cilexetil, irbesartan, losartan, telmisartan, and valsartan, are currently approved by the US Food and Drug Administration (FDA) for the treatment of patients with hypertension. These agents share a common mechanism of action-antagonism of the angiotensin type 1 (AT1) receptor-and ...
openaire +2 more sources
Angiotensin II receptor blockers for the treatment of hypertension
Expert Opinion on Pharmacotherapy, 2001The rising incidence of stroke, congestive heart failure (CHF) and end stage renal disease (ESRD) has signalled a need to increase awareness, treatment and control of hypertension. There continues to be a need for effective antihypertensive medications since hypertension is a major precursor to various forms of cardiovascular disease.
openaire +2 more sources
943: ANGIOTENSIN II USE IN ANGIOTENSIN RECEPTOR BLOCKER OVERDOSE
Critical Care Medicine, 2020Erin Goodwin +6 more
openaire +1 more source
Angiotensin‐II Biochemistry and Physiology: Update on Angiotensin‐II Receptor Blockers
Cardiovascular Drug Reviews, 1997Martin A. Bermann +2 more
openaire +1 more source
Angiotensin II receptor blockers and acute pancreatitis
2010BACKGROUND: Acute pancreatitis is a disease with potentially lethal consequences. The hormone angiotensin II inhibits the protective mucosa alkaline secretion in the duodenum via the angiotensin II type 1 receptor. A local pancreatic renin-angiotensin system affects enzyme secretion and inflammatory response in the pancreas.
openaire +1 more source
Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor Conformations
Cell, 2019Laura M Wingler +2 more
exaly